- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about RBGLY
Recent news which mentions RBGLY
From Benzinga
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
November 08, 2024
From Benzinga
Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst
September 19, 2024
From Benzinga
Consumer Giant Reckitt Seeks Help From Investment Banks To Evaluate Options For Homecare Brands, Baby Formula
September 18, 2024
From Benzinga
From InvestorPlace
Abbott Laboratories Tumble Nearly 8% In Pre-Market After US Jury Charges $495M Penalty For Disease Causing Baby Formula
July 29, 2024
From Benzinga
From Benzinga
What's Going On With Abbott Laboratories Stock On Friday?
March 15, 2024
From Benzinga
Durex Owner Reckitt Benckiser Taps Into China's Livestreaming Trend To Sell Condoms Online
February 29, 2024
From Benzinga
NVDA Stock on Fire: Can Potential Nvidia Investors Still Get In or Will They Get Burned?
January 28, 2024
From InvestorPlace
Reckitt's Mead Johnson Initiates Massive Recall Of 675K Cans Of Hypoallergenic Baby Formula Over Bacteria Contamination Fears
January 01, 2024
From Benzinga
From InvestorPlace
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
September 12, 2023
From Benzinga
FDA warns three baby-formula makers about production violations
August 30, 2023
From MarketWatch
3 Consumer Staples Stocks to Dump ASAP
August 02, 2023
From InvestorPlace
Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process
May 24, 2023
From Benzinga
7 Established Stocks That Are Poised for Growth in 2023
March 22, 2023
From InvestorPlace
Abbott Laboratories Under DOJ Investigation Into 2022 Baby Formula Plant Shutdown: Report
January 21, 2023
From Benzinga
Carlyle Pays $300M For Majority Ownership In India's VLCC
January 10, 2023
From Benzinga
From MarketWatch
Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report
December 02, 2022
From Benzinga
New Starbucks CEO To Focus On Unions, Pay And Benefits As Part Of 'Reinvention' Plan
September 04, 2022
From Benzinga
Why This Starbucks Analyst Is Surprised By New CEO Choice — And Optimistic
September 02, 2022
From Benzinga
Who is Starbucks’ new CEO? He has ‘deep’ knowledge of the consumer but lacks restaurant experience
September 02, 2022
From MarketWatch
Starbucks’ new CEO is a ‘world-class leader,’ founder Howard Schultz says
September 01, 2022
From MarketWatch
British Consumer Company Reckitt Benckiser's CEO Steps Down
September 01, 2022
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.